Wellgistics Health (WGRX) has secured contractual rights to preferred pricing for medical insurance eligibility and benefits verification that enables PharmacyChain for providers, partners and pharmacies in order to facilitate its faster adoption into the US healthcare ecosystem. EBV is crucial because it allows companies that engage in the distribution of medical products and services to know whether a particular product or service is covered by a patient’s insurance carrier and the level of coverage that patient has. This information is paramount to understand provider reimbursement levels and out-of-pocket costs for patients. Each time a provider requests EBV information, they must pay an out-of-pocket fee. Wellgistcs is making preferred pricing on this service available to providers, partners and its Wellgistics Pharmacy Network immediately through its EinsteinRx AI hub platform in preparation for integration into PharmacyChain later this year.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGRX:
- Wellgistics Launches Forzet Medical Food for GLP-1 Patients
- Wellgistics Health launches Forzet for muscle loss linked with weight loss drugs
- Wellgistics selects five blockchain platforms for PharmacyChain development
- Datavault, Wellgistics Health announce plans to expand partnership
- Wellgistics Health completes investment in mental health AI startup
